J&J Restructure: Will Cost Cuts Affect Suppliers?
This morning Bloomberg is reporting that Johnson & Johnson has raised its sales forecast, but with it comes a restructuring of its global supply chain. The plan could generate up to $800 million in annual pretax savings by 2022, and the restructure could affect J&J’s suppliers, according to Bloomberg.
Seeking Alpha reports that several suppliers have exposure to this plan, including Universal Biosensors, Stereotaxis, Stratasys, Tokyo Automatic Machinery, Samsung Biologics and Charles River Labs.